Search

Mobile technologies to support global ear and hearing care

By combining mobile technology with artificial intelligence, more people can access ear and hearing care. The World Health Organization (WHO) estimates that worldwide, nearly half a billion people have moderate or worse hearing loss [1]. The vast majority of people...

The doctor – pharmaceutical company relationship

‘Which drug rep is taking us out tonight?’ We have heard this phrase uttered at conferences since meetings began, but as Dylan said ‘those times they are a changing’ thanks to the Association of the British Pharmaceutical Industry (ABPI) and...

Training in the use of medical devices
– how should it be done?

Adequate training in novel medical devices is imperative, not only to ensure patient safety, but also to give clinicians the confidence to use the device in question. In this article, Andrea Gillies explains the philosophy of one of the equipment...

Improving cochlear-implant performance in the short- and medium-term

Can bespoke cochlear implant programming strategies reduce the variability seen in patient performance with an implant? Bob Carlyon reviews the current situation and gives us a glimpse of the future. Although many cochlear implant (CI) patients understand speech well in...

Clinical management: 
a personal view

When Nigel Beasley approached me to write on my experience of clinical management, I was a little surprised. I see myself as primarily a clinician, but have had increasing involvement with clinical management within my Trust. I am now in...

TEN testing in paediatric patients

Threshold equalising noise (TEN) testing is used to identify dead regions (DRs) of the cochlear. Alexandra Lusty considers the challenges of using the TEN test in the paediatric population as well as the importance of identifying DRs. Diagnosing dead regions...

Human immunodeficiency virus and hearing impairment

With an estimated 36.7 million individuals living with HIV / AIDS and literature reporting that these conditions contribute to hearing loss, it is surprising that more focus and resources are not employed to tackle this major hearing health concern. Yolandé...

The common frontal sinusotomy (Lothrop) and chronic rhinosinusitis

As our understanding of the pathophysiology of CRS evolves, so do our treatment strategies. It is accepted that in many cases, the main role of surgery is to allow better penetration of topical therapies to the sinus cavities. What, then,...

Hearing and balance clinical trials network (HEARING CTN)

About the HEARING CTN The HEARING CTN is a new UK research network focused on promoting research collaboration and supporting high quality research studies, with the aim of improving the evidence supporting the diagnosis and management of hearing loss and...

Effective and profitable provision of paediatric audiology care in the private sector

Similar to other specialty areas of hearing healthcare, paediatric audiology is a potential net loss for a private-sector, for-profit, business. Given the time-intensive needs of patients with cochlear implants, tinnitus and those who are under the age of 18 years...

Clinical leadership and management: developing world ENT

I have been asked to share some of the initiatives I have been involved with to address ENT-related challenges in Africa and the developing world. Developing countries constitute the majority of the world’s landmass (Figure 1), are home to >50%...